Immatics
Bettina Brackertz is an experienced professional in clinical safety and pharmacovigilance, currently serving as Associate Director Clinical Safety at Immatics since October 2021, following roles as Principal Manager and Senior Manager in the same field. Prior to this, Bettina worked at MorphoSys AG from May 2012 to September 2021, holding positions as Manager Drug Safety & Pharmacovigilance, Lead Scientist, and Postdoktorand. Bettina’s early career included a role as Postdoktorand at Hämatologikum München and at the DKFZ German Cancer Research Center, where a scholarship was received. Bettina holds a Dr. rer. nat. in Hämatologie, Onkologie, and Immunologie from Klinikum rechts der Isar/TU München and a Diplom-Biologe in Immunologie from The Julius Maximilians University of Würzburg. Additionally, Bettina has international experience from Université Paul Sabatier Toulouse III.
This person is not in any teams
This person is not in any offices
Immatics
9 followers
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.